Stay updated on INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.

Latest updates to the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page
- Check5 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3; no study content or essential page data appears to be affected.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as the previous Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding lapse notice about the NIH Clinical Center status and updated the page revision to v3.4.1, while removing the previous v3.4.0 reference.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary toggle (Show glossary) and made minor wording changes to metadata, including capitalization tweaks and a new Revision: v3.4.0. These updates replace the previous wording (met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 appears on the page in place of v3.3.3, with no observable changes to study details, enrollment, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. These changes are administrative and do not alter the study content or data presented on the page.SummaryDifference0.1%

Stay in the know with updates to INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.